We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+5.21%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$1.83B
AUM Growth
-$162M
Cap. Flow
-$224M
Cap. Flow %
-12.21%
Top 10 Hldgs %
10.93%
Holding
2,251
New
495
Increased
616
Reduced
729
Closed
395

Sector Composition

Rank Sector Weight
1 Technology 17.35%
2 Financials 12.93%
3 Industrials 11.95%
4 Consumer Discretionary 11.81%
5 Healthcare 11.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUBB icon
1701
Hubbell
HUBB
$27.2B
$53K ﹤0.01%
399
-656
-62% -$80.5K
SIMO icon
1702
Silicon Motion
SIMO
$8.68B
$52K ﹤0.01%
965
+826
+594% +$45.7K
DRD
1703
DRDGold
DRD
$2.05B
$51K ﹤0.01%
21,005
PACB icon
1704
Pacific Biosciences
PACB
$370M
$51K ﹤0.01%
+9,409
New +$40.4K
PBA icon
1705
Pembina Pipeline
PBA
$27.6B
$50K ﹤0.01%
1,475
-9,487
-87% -$329K
MR
1706
DELISTED
Montage Resources Corporation Common Stock
MR
$50K ﹤0.01%
+2,796
New +$64K
LTS
1707
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$50K ﹤0.01%
+18,453
New +$59.5K
CVEO icon
1708
Civeo
CVEO
$318M
$49K ﹤0.01%
989
-5,393
-85% -$253K
CYOU
1709
DELISTED
Changyou.com Limited American Depositary Share
CYOU
$49K ﹤0.01%
+3,713
New +$53.4K
BXE
1710
DELISTED
Bellatrix Exploration Ltd.
BXE
$49K ﹤0.01%
46,266
CLLS
1711
Cellectis
CLLS
$285M
$48K ﹤0.01%
+1,714
New +$49.2K
IONS icon
1712
Ionis Pharmaceuticals
IONS
$9.4B
$48K ﹤0.01%
+924
New +$43.4K
OBSV
1713
DELISTED
ObsEva SA Ordinary Shares
OBSV
$48K ﹤0.01%
2,662
-1,576
-37% -$23.2K
AGEN
1714
Agenus
AGEN
$290M
$47K ﹤0.01%
1,121
-681
-38% -$26.8K
ARES icon
1715
Ares Management
ARES
$30.9B
$47K ﹤0.01%
2,040
-3,273
-62% -$70.2K
MX icon
1716
Magnachip Semiconductor
MX
$145M
$47K ﹤0.01%
4,785
+3,120
+187% +$34.3K
TTOO
1717
DELISTED
T2 Biosystems, Inc
TTOO
$47K ﹤0.01%
+1
New +$32.9K
TGA
1718
DELISTED
Transglobe Energy Corp
TGA
$47K ﹤0.01%
14,222
-10,525
-43% -$35.2K
APRN
1719
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$46K ﹤0.01%
+149
New +$65.3K
XLRN
1720
DELISTED
Acceleron Pharma
XLRN
$46K ﹤0.01%
806
-4,533
-85% -$223K
FLXN
1721
DELISTED
Flexion Therapeutics, Inc.
FLXN
$46K ﹤0.01%
+2,432
New +$55.9K
ATHX
1722
DELISTED
Athersys, Inc. Common Stock
ATHX
$45K ﹤0.01%
853
-415
-33% -$20.6K
ANW
1723
DELISTED
Aegean Marine Petroleum Network
ANW
$45K ﹤0.01%
31,335
-17,836
-36% -$30.1K
OLED icon
1724
Universal Display
OLED
$4.19B
$44K ﹤0.01%
+376
New +$41.3K
SSTK icon
1725
Shutterstock
SSTK
$219M
$44K ﹤0.01%
+806
New +$41.5K

Similar funds

Cubist Systematic Strategies's Q3 2018 Portfolio in Review

As of Q3 2018, Cubist Systematic Strategies held 2,251 positions worth $1.83B, down 8.1% from $1.99B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Cubist Systematic Strategies withdrew a net $224M in Q3 2018, closing 395 positions and reducing 729 holdings. Its most notable exit was RealPage, Inc., an estimated $7.21M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

Against the trend, Cubist Systematic Strategies opened a new position in NXP Semiconductors worth $17.6M.

  • Cubist Systematic Strategies's largest Q3 2018 buy was NXP Semiconductors: 205,779 shares worth $17.6M.
  • Cubist Systematic Strategies added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $65.8M increase.
  • Cubist Systematic Strategies's biggest Q3 2018 reduction was Just Eat Takeaway.com N.V. American Depositary Shares, cutting an estimated $13.2M.
  • Cubist Systematic Strategies fully exited RealPage, Inc. in Q3 2018, selling an estimated $7.21M.
  • Cubist Systematic Strategies's ten largest holdings make up 11% of its $1.83B portfolio in Q3 2018.
  • Cubist Systematic Strategies opened 495 new positions and closed 395 in Q3 2018.
  • Cubist Systematic Strategies's portfolio value fell 8.1% quarter-over-quarter to $1.83B.

Based on Cubist Systematic Strategies's 13F filing for Q3 2018, filed 14 Nov 2018.